Identification | Back Directory | [Name]
Carbamic acid, (6-methyl-3-pyridinyl)-, 1,1-dimethylethyl ester (9CI) | [CAS]
323578-37-6 | [Synonyms]
6-methylpyridin-3-ylcarbamate tert-Butyl (6-methylpyridin-3-yl) tert-butyl 6-methylpyridin-3-ylcarbamate Tert butyl 6- methyl pyridine -3- carbamate tert-butyl N-(6-methylpyridin-3-yl)carbamate Carbamic acid, (6-methyl-3-pyridinyl)-, 1,1- (6-Methyl-pyridin-3-yl)-carbaMic acid tert-butyl ester (6-Methyl-3-Pyridinyl)-Carbamic Acid 1,1-Dimethylethyl Ester Carbamic acid, N-(6-methyl-3-pyridinyl)-, 1,1-dimethylethyl ester Carbamic acid, (6-methyl-3-pyridinyl)-, 1,1-dimethylethyl ester (9CI) | [Molecular Formula]
C11H16N2O2 | [MDL Number]
MFCD13192526 | [MOL File]
323578-37-6.mol | [Molecular Weight]
208.26 |
Chemical Properties | Back Directory | [Melting point ]
114-115 °C(Solv: hexane (110-54-3); ethyl acetate (141-78-6)) | [Boiling point ]
262.7±28.0 °C(Predicted) | [density ]
1.108±0.06 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,Room Temperature | [pka]
12.94±0.70(Predicted) | [Appearance]
White to off-white Solid |
Hazard Information | Back Directory | [Synthesis]
Step 1. Synthesis of tert-butyl (6-methylpyridin-3-yl)carbamate. Di-tert-butyl dicarbonate (55.5 g, 298 mmol) was slowly added dropwise to a solution of 6-methylpyridin-3-amine (25 g, 231 mmol) in ethanol (100 mL) at 0 °C. After the dropwise addition, the reaction mixture was stirred at room temperature overnight. The progress of the reaction was monitored by TLC (unfolding agent: petroleum ether/ethyl acetate, 2:1) to confirm complete consumption of 6-methylpyridin-3-amine. Upon completion of the reaction, the reaction mixture was filtered and the filter cake was washed with ethanol (30 mL x 3). The filtrates were combined and concentrated under reduced pressure to give a yellow residue. This residue was purified by column chromatography (eluent: petroleum ether/ethyl acetate, 4:1 to 1:1) to afford tert-butyl (6-methylpyridin-3-yl)carbamate (32.5 g, 67.4% yield) as a white solid.1H NMR (400 MHz, CDCl3) δ 8.30 (d, J = 2.0 Hz, 1H), 7.86 (br s, 1H) 7.10 (d, J = 8.5 Hz, 1H), 6.57 (br s, 1H), 2.49 (s, 3H), 1.51 (s, 9H). Step 2. Synthesis of racemic-cis/trans-tert-butyl (6-methylpiperidin-3-yl)carbamate. Platinum oxide (2.5 g) was added to a dry hydrogenation flask under argon protection. Then a solution of tert-butyl (6-methylpyridin-3-yl)carbamate (33 g, 158.5 mmol) in acetic acid (300 mL) was added, and the resulting mixture was hydrogenated at 50 °C under 55 psi hydrogen pressure for 30 hours. The progress of the reaction was monitored by TLC (unfolding agent: petroleum ether/ethyl acetate, 2:1) to confirm complete consumption of the starting material. Upon completion of the reaction, the reaction mixture was filtered and the filter cake was washed with methanol (50 mL x 2). The filtrates were combined and evaporated under reduced pressure to afford tert-butyl (6-methylpiperidin-3-yl)carbamate (34 g, 100% yield) as a yellow oil (cis/trans ratio 2:1), which was used directly in the next step of the reaction without further purification.LC/MS (M + H) 215.2. | [References]
[1] Patent: US2015/158864, 2015, A1. Location in patent: Paragraph 0270 [2] Journal of Medicinal Chemistry, 2017, vol. 60, # 5, p. 1971 - 1993 [3] Patent: WO2012/148775, 2012, A1. Location in patent: Page/Page column 113; 114 [4] Patent: WO2010/16005, 2010, A1. Location in patent: Page/Page column 135-136 [5] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 22, p. 5580 - 5590 |
|
Company Name: |
Tetranov Biopharm
|
Tel: |
13526569071 |
Website: |
http://www.leadmedpharm.com/index.html |
|